From antiretroviral therapy to vaccines, where we are today and what’s next.
Keeping your clinical trial on track in an evolving environment.
Transforming recruitment through patient-centric trials and real-world, real-time data.
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
From recruitment of a single clinical professional to managing entire global functions.
ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars.
FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.
The blog considers current perspectives on the use of biomarkers, differences between the needs of biomarker assays developed for use in bioanalytical labs or clinical labs, and what may be needed in the case that a biomarker assay needs to migrate into a CLIA lab.